0001144204-18-065469.txt : 20181219
0001144204-18-065469.hdr.sgml : 20181219
20181219190025
ACCESSION NUMBER: 0001144204-18-065469
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181217
FILED AS OF DATE: 20181219
DATE AS OF CHANGE: 20181219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shapiro David
CENTRAL INDEX KEY: 0001559570
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35668
FILM NUMBER: 181244406
MAIL ADDRESS:
STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC.
STREET 2: 18 DESBROSSES ST.
CITY: NEW YORK
STATE: NY
ZIP: 10013
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001270073
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223868459
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 HUDSON YARDS, 37TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: 646-747-1000
MAIL ADDRESS:
STREET 1: 10 HUDSON YARDS, 37TH FLOOR
CITY: New York
STATE: NY
ZIP: 10001
FORMER COMPANY:
FORMER CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20031113
4
1
tv509353_4.xml
OWNERSHIP DOCUMENT
X0306
4
2018-12-17
0
0001270073
INTERCEPT PHARMACEUTICALS, INC.
ICPT
0001559570
Shapiro David
C/O INTERCEPT PHARMACEUTICALS, INC.
10 HUDSON YARDS, FLOOR 37
NEW YORK
NY
10001
0
1
0
0
Chief Medical Officer
Common Stock
2018-12-17
4
M
0
2000
31.90
A
41152
D
Common Stock
2018-12-17
4
S
0
2000
106.62
D
39152
D
Option to Purchase Common Stock
31.90
2018-12-17
4
M
0
2000
0
D
2023-05-07
Common Stock
2000
19031
D
This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.
This option is fully vested and exercisable.
/s/ Mark Pruzanski, as attorney-in-fact
2018-12-19